Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility (Q35134480)

6 August 2017

1 reference

title

Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility (English)

1 reference

6 August 2017

Fournier E

1

1 reference

6 August 2017

Passirani C

series ordinal

2

1 reference

6 August 2017

Montero-Menei CN

series ordinal

3

1 reference

6 August 2017

Benoit JP

series ordinal

4

1 reference

6 August 2017

1 August 2003

1 reference

6 August 2017

21

1 reference

inferred from page(s)

published in

Biomaterials

1 reference

6 August 2017

24

1 reference

6 August 2017

19

1 reference

6 August 2017

3311-3331

1 reference

Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Reducing capsular thickness and enhancing angiogenesis around implant drug release systems

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biomaterial-microvasculature interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immunocompatibility and biocompatibility of cell delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Host response to tissue engineered devices

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Cell replacement therapies for central nervous system disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Targeted drug delivery for brain cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Fate and biocompatibility of three types of microspheres implanted into the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Polymeric chitosan-based vesicles for drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Modern drug delivery applications of chitosan

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Protein release from collagen matrices

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Sugar cross-linked gelatin for controlled release: microspheres and disks

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Characterization of subcutaneous Contramid implantation: host response and delivery of a potent analog of the growth hormone-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

The biocompatibility of novel starch-based polymers and composites: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Nanoparticulate systems for brain delivery of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Does surface chemistry affect thrombogenicity of surface modified polymers?

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Block copolymer micelles for delivery of gene and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

alpha,beta-poly(asparthylhydrazide)-glycidyltrimethylammonium chloride copolymers (PAHy-GTA): novel polymers with potential for DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Inflammatory responses to biomaterials

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Mechanisms of fibrinogen domains: biomaterial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immune response in biocompatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immune regulation within the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Factors controlling T-cell migration across rat cerebral endothelium in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Basic principles of immunological surveillance of the normal central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Molecular and cellular permeability control at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Glial cell influence on the human blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

The microglial cell. A historical review

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Microglia: activation and their significance in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Astrocyte responses to CNS injury

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immune function of astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Role of astrocytes in antigen presentation and naive T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

TGF-beta: a critical modulator of immune cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

New clues about vitamin D functions in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

The cage implant system for determining in vivo biocompatibility of medical device materials

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biological performance of a degradable poly(lactic acid-epsilon-caprolactone) nerve guide: influence of tube dimensions

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-epsilon-caprolactone)

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

The role of FasL-induced apoptosis in immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immune privilege: keeping an eye on natural killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Microspheres and nanoparticles used in ocular delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biodegradable scleral plugs for vitreoretinal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biodegradable scleral implant for intravitreal controlled release of fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Hydrogels in pharmaceutical formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

In vivo tissue compatibility of two radio-opaque polymeric biomaterials

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Sustained local drug delivery from a radiopaque implanted reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

HPMA-based biodegradable hydrogels containing different forms of doxorubicin. Antitumor effects and biocompatibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: human serum proteins in vitro and rat proteins following implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Making microencapsulation work: conformal coating, immobilization gels and in vivo performance

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Poly(anhydride-co-imides): in vivo biocompatibility in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Ricinoleic acid-based biopolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Sterilization, storage stability and in vivo biocompatibility of poly(trimethylene carbonate)/poly(adipic anhydride) blends

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Poly(ortho esters) - their development and some recent applications

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Therapeutic applications of viscous and injectable poly(ortho esters).

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Development of a poly(ortho ester) prototype with a latent acid in the polymer backbone for 5-fluorouracil delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Subconjunctival biocompatibility of a viscous bioerodable poly(ortho ester)

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Toxicology of polymers for implant contraceptives for women

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Immune defects observed in patients with primary malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Site-specific immune response to implanted gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Carboplatin-Loaded PLGA Microspheres for Intracerebral Implantation: In Vivo Characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Direct intracerebral delivery of carboplatin from PLGA microspheres against experimental malignant glioma in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Histopathological evaluation of materials implanted in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Analysis of brain biocompatibility of drug-releasing biodegradable microspheres by scanning and transmission electron microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

The fate of biodegradable microspheres injected into rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Viability and protein secretion from human Hepatoma (HepG2) cells encapsulated in 400-mum polyacrylate microcapsules by submerged nozzle-liquid jet extrusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Evaluation of reaction of primate brain to grafted PC12 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biocompatibility of HEMA copolymers designed for treatment of CNS diseases with polymer-encapsulated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biological properties of copolymer of 2-hydroxyethyl methacrylate with sulfopropyl methacrylate

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Anionic polymers for implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Comparative study of human monocyte and platelet adhesion to hydrogels in vitro - effect of polymer structure

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Brain biocompatibility of a biodegradable, controlled-release polymer in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

Histological analysis of microencapsulated dopamine-secreting cells in agarose/poly(styrene sulfonic acid) mixed gel xenotransplanted into the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900161-3

7 January 2021

10.1016/S0142-9612(03)00161-3

Identifiers

DOI

1 reference

6 August 2017

1 reference